I refer to the 4C yesterday and the Investor Briefing this morning and the thing that annoys me (and the reason I bought before this 4C) was the following comment in the annual report.....
...management stated a 20% and (implied) growing monthly run rate when they absolutely knew that January results were inconsistent with that!
... and don't get me started on the deferral, by 6 months, of the US FDA approval...
Now to adjust my trust meter for AXP Management!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.355M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.1¢ | 0.1¢ | $3.722K | 3.722M |
| AXP (ASX) Chart |